Trial Profile
A Phase 1b/2 IS Trial of CYC065 in pediatric patients with neuroblastoma
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 18 May 2018
Price :
$35
*
At a glance
- Drugs Fadraciclib (Primary)
- Indications Neuroblastoma
- Focus Therapeutic Use
- 18 May 2018 New trial record
- 14 May 2018 According to a Cyclacel Pharmaceuticals media release, the company is planning to start enrollment in this trial in 2018.